0001131096-16-000363.txt : 20160728
0001131096-16-000363.hdr.sgml : 20160728
20160728173345
ACCESSION NUMBER: 0001131096-16-000363
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160727
FILED AS OF DATE: 20160728
DATE AS OF CHANGE: 20160728
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ATHENAHEALTH INC
CENTRAL INDEX KEY: 0001131096
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 043387530
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 311 ARSENAL STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
BUSINESS PHONE: 617-402-1000
MAIL ADDRESS:
STREET 1: 311 ARSENAL STREET
CITY: WATERTOWN
STATE: MA
ZIP: 02472
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KANE JOHN A
CENTRAL INDEX KEY: 0001049356
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
STATE OF INCORPORATION: VT
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33689
FILM NUMBER: 161791208
MAIL ADDRESS:
STREET 1: C/O MERCHANTS BANCSHARES, INC.
STREET 2: 275 KENNEDY DRIVE
CITY: SOUTH BURLINGTON
STATE: VT
ZIP: 05403
4
1
wf-form4_146974161203201.xml
FORM 4
X0306
4
2016-07-27
0
0001131096
ATHENAHEALTH INC
ATHN
0001049356
KANE JOHN A
C/O ATHENAHEALTH, INC.
311 ARSENAL STREET
WATERTOWN
MA
02472
1
0
0
0
Common Stock
2016-07-27
4
M
0
2875
15.27
A
10708
D
Common Stock
2016-07-27
4
S
0
2875
128.81
D
7833
D
Stock Option (Right to Buy)
15.27
2016-07-27
4
M
0
2875
0
D
2007-07-26
2017-07-26
Common Stock
2875.0
6875
D
The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on February 25, 2015, in accordance with Rule 10b5-1.
Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.21 to $129.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).
/s/ Lan Marinelli
Attorney-in-Fact
2016-07-28